News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Konan Medical USA Inc. Release: Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at EuroPCR Meeting in Paris



5/23/2013 9:09:06 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Kona Medical announced that three and six month results from the WAVE I study were presented today at the late-breaking clinical trials session of EuroPCR in Paris by Robert Whitbourn, MD, of St. Vincent’s Hospital in Melbourne, Australia. WAVE I is a first-in-man study evaluating the safety and efficacy of Kona Medical’s Surround Sound® Renal Denervation System for the treatment of resistant hypertension.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES